{"ticker": {"uuid": "2ed2474e-3ed9-4cf8-a093-5d975c5f1064", "symbol": "RADX", "name": "Radiopharm Theranostics Limited American Depositary Shares", "exchange": "NASDAQ", "country": "US", "sector": "Healthcare", "industry": "Biotechnology"}, "articles": [{"title": "Q1 Earnings Highs And Lows: Natera (NASDAQ:NTRA) Vs The Rest Of The Biotechnology Stocks", "summary": "", "url": "https://news.google.com/rss/articles/CBMilAFBVV95cUxNYmZ3aHMyMjBuNmlEUGN6NWZBZV85cEFWNndJaVNoNEVYNk84MlNKRXJ0RXpRQl9wN1RsekhxM3loY1RRNDJhTnVremtReHhLQWVHS053VzRBUTduSkdqRGt1YkxMMThqZHoydElPX1Zfd3hEMi15VlRwRGRvZ2JqRDFneVVxN0JCYzQ4QlV5TTBEOWx3?oc=5", "source_name": "Market source", "published_at": "2026-07-16T18:49:22+00:00", "published_display": "16 Jul 2026 18:49", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "industry", "tier_label": "Industry context"}, {"title": "Unpacking Q1 Earnings: Incyte (NASDAQ:INCY) In The Context Of Other Biotechnology Stocks", "summary": "", "url": "https://news.google.com/rss/articles/CBMigAJBVV95cUxPV1hqSFhQM3VfYlNsdldfeVQ1dEdNNzI3S1RTaFJNSThrOXlPSWpMTlR5WWVxNnNsTzhTVGVvTE94R18wa1A0OUdFczBlcTIzeUFBZUt6VVJJMjNqNks3dmRUSzB4cE40anpNekJwUXAwcTFEcVh4QVZCYURXY2w4b2thdk5KZ3ZJMnI1REJObXo5UDdISXVCU1Z2ZVZoVmJpbnEzaDVWVmpGQVNFZzRXYnp0SWRRWWZGSnZnWlJ4aEloNmJBNGRMVFRjb3ZRbmV3QXF5S0pvTV9xNnpaMWV1Z1ZtM3lPdV9RcEdURHlfZFphdjlicEJndW0ybHNBa205?oc=5", "source_name": "The Globe and Mail", "published_at": "2026-07-13T03:32:00+00:00", "published_display": "13 Jul 2026 03:32", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "industry", "tier_label": "Industry context"}, {"title": "A$5,885,131 R&D tax refund supports Radiopharm Theranostics (Nasdaq: RADX)", "summary": "", "url": "https://news.google.com/rss/articles/CBMiwAFBVV95cUxOSVJ0WHdqMURkdlFYQ2tFLTdiTEc1X185LXlwM3UtUmpyek9Hb2NTdlp0ejBFRUxxWWg0VzRwU29CTWFIN3hFZnhrY0hPQ1dibDVoUWJFc1huaUlTZ1dhaE5TYUVnZ1Z4VURnMHVBQmZTeHF4VDc3UHdNeE5qWHFYbTB1OE9CRmpZNHFNR0plYmNfWVhNSFpVUEMyYldLN0hLQlNUZVNhZktTSVlDOUJ2V2FoMURJcjI5SHRuTnpYS3Y?oc=5", "source_name": "Stock Titan", "published_at": "2026-07-06T07:00:00+00:00", "published_display": "06 Jul 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Theranostics (NASDAQ: RADX) reports option lapses and new RADAN grants", "summary": "", "url": "https://news.google.com/rss/articles/CBMiwAFBVV95cUxNQmNpMzlMSEhwbWNIaDZzNHZvOGtEU1BnbEdzdzg1andGSkQwRW9Ydk1pRkpmUC1oMjVGemZ1SXBhUzJPckZfZjZqTVVncFU5U2RaSTYwalRNc2JueEQyY1lWU1k0c3R0Z0lmTVV3ZXZJdzQ1ZWpDTWZXQld4ZDNMclRhNnlkS0s4ZktEdTJCbG9ycVpWeXBzX1B6a1FIRE9iTnFpcW15aWJ4cWswWkVfQVJ3ckk5TWpaRWpHZFRqZDA?oc=5", "source_name": "Stock Titan", "published_at": "2026-06-30T07:00:00+00:00", "published_display": "30 Jun 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Radiopharm Theranostics Ltd (RADX) Institutional Confidence", "summary": "", "url": "https://news.google.com/rss/articles/CBMicEFVX3lxTE9kNDUxMlRHdkZVc0hPSGxLUzlLWDhhX1NZUDJrM2ZzN3BZZlFDbFl6RTBFc1poc1JaemNHNlRHdkNfVmlFYml3LXo0bGxiRmhaN0FQbXpfdjFSZHR6c1lBdVRiYU1DQWpUMDM3WW5wal8?oc=5", "source_name": "TradingKey", "published_at": "2026-06-18T01:48:47+00:00", "published_display": "18 Jun 2026 01:48", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Radiopharm Theranostics (RADX) Gains 1.73% as Stock Hovers Above Key Support at $4.13 - Double Top", "summary": "", "url": "https://news.google.com/rss/articles/CBMiwgFBVV95cUxPSERYaTFmT0VYcGxtUFN4MWN1NzBEUVA5eEVxR19UZ29BY0lzYkxFeW5jQ05BMldfMWZxejRIN0wyVzNreHRJZVhLeW5wYy1nSkZOMkEzTk5fb2lhZzFMSEx2TzRBVGdRcFREc2RJMDl5N0JKVnV4djBpZnlZSER6Y3hiUzc3WVAtUk1PYXNGd1htUnJuUEZIOGtMbzRjbF82WUpfRHF0a2wxSkFkNEFqdkFwUnNud2hyQVRNNVh2cjBHQQ?oc=5", "source_name": "dars.gov.et", "published_at": "2026-06-10T07:00:00+00:00", "published_display": "10 Jun 2026 07:00", "sentiment": "positive", "sentiment_pct": 66, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Radiopharm Theranostics (RADX) Gains Ground: Testing Key Resistance at $4.85 - Fear Greed Extreme", "summary": "", "url": "https://news.google.com/rss/articles/CBMitwFBVV95cUxOVkdwNGhraGpSUG9tOVhlOVpDSDJqVGVaS3R1QUZCQ21OMTNEZFN3X0R2Mlp1N3RTU2xycUpQcExrNW95LVhUNGZYSXpqYy1qbzN2NnZUR2hNVG5qZGlMdXV6TGFrWk5xcWF3aWN6dnhJN2lLa2p0MkVNV0VTTFpxcUNTelRzc3gyUkVuUERQVVdiZk9NVDd3X2VjYWtBQUZEb1FTYzBEZ0V4YTVpckxyb05LcDE3Mms?oc=5", "source_name": "dars.gov.et", "published_at": "2026-05-28T07:00:00+00:00", "published_display": "28 May 2026 07:00", "sentiment": "positive", "sentiment_pct": 66, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "There May Be Reason For Hope In Puma Biotechnology's (NASDAQ:PBYI) Disappointing Earnings", "summary": "", "url": "https://news.google.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?oc=5", "source_name": "simplywall.st", "published_at": "2026-05-15T07:00:00+00:00", "published_display": "15 May 2026 07:00", "sentiment": "negative", "sentiment_pct": 34, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "industry", "tier_label": "Industry context"}, {"title": "Puma Biotechnology's (NASDAQ:PBYI) Conservative Accounting Might Explain Soft Earnings", "summary": "", "url": "https://news.google.com/rss/articles/CBMirgFBVV95cUxNZXcyN1VKc0J0RTFtSER6TGRSZm8xSWs2c0paem5paDd3V0J1cjF6ajhFb29tRFpUWWpxYUhzZjFkSXhYQ0lBNTVlbTdCRERpSXNjaGpDajFPOVlpRS1qV2xHMTRHS2pjVVBZMWFfNzItWE9FeENtQ2duMUxVQm5kOG41eVlrNUpObXp2VlhfekdhMVh2X0hjN3ZFZThZNUdWakFLUXJ4aFBVN2JyR2c?oc=5", "source_name": "Market source", "published_at": "2026-05-14T07:00:00+00:00", "published_display": "14 May 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "industry", "tier_label": "Industry context"}, {"title": "Puma Biotechnology, Inc. (NASDAQ:PBYI) Analysts Are Pretty Bullish On The Stock After Recent Results", "summary": "", "url": "https://news.google.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?oc=5", "source_name": "simplywall.st", "published_at": "2026-05-11T07:00:00+00:00", "published_display": "11 May 2026 07:00", "sentiment": "positive", "sentiment_pct": 66, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "industry", "tier_label": "Industry context"}, {"title": "Earnings Update: Here's Why Analysts Just Lifted Their Puma Biotechnology, Inc. (NASDAQ:PBYI) Price Target To US$5.00", "summary": "", "url": "https://news.google.com/rss/articles/CBMingFBVV95cUxPSUN3RjZYMEJ2VUdKQjJpRkZaUXRzM2NTa05WWmlmWHJnZDlJeUpTdFM5Wmk0SUhjclU2dldTZFIyRmZZeGJSNGM2SUNiSGJSYjh1VjYyR0hPZ2FJbWdsbHExYlhwMW1HRTZ0NUxwQzU1b2g4MGpwSHdoMkdIOUtqOXBBYk92LVk2cEFZMzVISjB3c04ydVBEYWw2cVVsdw?oc=5", "source_name": "Market source", "published_at": "2026-05-11T07:00:00+00:00", "published_display": "11 May 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "industry", "tier_label": "Industry context"}, {"title": "Radiopharm Theranostics Highlights Phase 1 Pipeline, Eyes June RAD 101 Data at DB Conference", "summary": "", "url": "https://finance.yahoo.com/m/248f9258-8866-3027-a2da-7b029e642c2b/radiopharm-theranostics.html", "source_name": "MarketBeat", "published_at": "2026-04-29T09:04:38+00:00", "published_display": "29 Apr 2026 09:04", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Radiopharm Theranostics ADR (RADX): Inside the Clinical Programs", "summary": "", "url": "https://news.google.com/rss/articles/CBMirAFBVV95cUxNRGstejdNa3B1OXpsaEJ3dk5ibVJicl9QLXhfSFIyamdxLVdEajNWbG1HeTFZMnBGNWEtOHZZVHFlaXdDU2t4UkI3YkFHeUZ5dmZvVzNiVXJweU1zQzVGZzZRUWxKRG1PUmtHMXVQUVJucFUwTlVvajlCLWFyVWwyLWt2M3dFY0VfOVBHUV9zM2FpOXZfTHhhQlJBb0VMY20zYVRGb2ZNMUlpUks4?oc=5", "source_name": "Market source", "published_at": "2026-04-28T07:00:00+00:00", "published_display": "28 Apr 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Q4 Earnings Highlights: Regeneron (NASDAQ:REGN) Vs The Rest Of The Biotechnology Stocks", "summary": "", "url": "https://news.google.com/rss/articles/CBMirAFBVV95cUxNWW9GYm5uRzlBX2ZiZXA3RkdDXzJhaFd2N1ZwR21jaXhiRkZQSTNHT0hMaUFjSGl6VXZfOURKemF2bWlFS1hKTXBjZUw4amdVQ0I4QlVnNmFkY1VTQ25pUjBiZGNDUE9QdWdOZHAxV1I1ejN6UE9WdGpseUdrMVA5MXBXWXJmWDBkZUdWUkxpOURCdlZlbDlQR3M5cjAzaDFtakFNblRTa3c0Q1J6?oc=5", "source_name": "Market source", "published_at": "2026-04-25T07:00:00+00:00", "published_display": "25 Apr 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "industry", "tier_label": "Industry context"}, {"title": "International companies to host live webcasts at Deutsche Bank\u2019s Depositary Receipts Virtual Investor Conference on April 28, 2026", "summary": "", "url": "https://finance.yahoo.com/markets/world-indices/articles/international-companies-host-live-webcasts-123500314.html", "source_name": "GlobeNewswire", "published_at": "2026-04-23T12:35:00+00:00", "published_display": "23 Apr 2026 12:35", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Radiopharm Theranostics Reports Business Update", "summary": "", "url": "https://news.google.com/rss/articles/CBMirgFBVV95cUxOc2dKN3BtcF82TlJscmVWMEQ0Y0N3U2dxek42VVQxLXB0WWNDNVdiNGZuaTVLc25zNlo3emdtUHlsNE5wN1N6SVEyYTlCV01oT1lUWlZpLW5SQ0VIelRDdkFDbVBicVBkeUVvUWdMWUdfTUtwcjlxTEpPcUF0bFIxX3V2VlhDY2ZlZTg4TUpYd1htU243X01XN255N2U0VHZzLTFpMUZiZEVkQXFFMXc?oc=5", "source_name": "Market source", "published_at": "2026-04-23T07:00:00+00:00", "published_display": "23 Apr 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Biotechnology Stocks Q3 Results: Benchmarking Natera (NASDAQ:NTRA)", "summary": "", "url": "https://news.google.com/rss/articles/CBMiswFBVV95cUxPZzZDSEhwNlVYQU9kNXBMMU5ia0FTU0RxRlYwb0I1RERNODN4N0VwRFZWMUY4ODh3eWNkTkp0UERreFlSTllocGk4a2ZKcGlJVjQ4d1dXWlNnYTc5UlNMZm4wc2xITjRQVzhRb3Z5LXllQmhvUHNIaXB3LXk1RUw1WnRPam9wcVE1MXFxSmVzVF9MVmRyMWIwdVkxS1N3MUJZUzByLWxrVDlSSUk4QnNsXzJYbw?oc=5", "source_name": "Market source", "published_at": "2026-04-21T07:00:00+00:00", "published_display": "21 Apr 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "industry", "tier_label": "Industry context"}, {"title": "Radiopharm Theranostics Presents Initial Findings from Phase 1 First-in-Human HEAT Clinical Trial for 177Lu-RAD202 in HER2+ Solid Tumors at American Association for Cancer Research 2026", "summary": "", "url": "https://finance.yahoo.com/sectors/healthcare/articles/radiopharm-theranostics-presents-initial-findings-110000207.html", "source_name": "GlobeNewswire", "published_at": "2026-04-20T11:00:00+00:00", "published_display": "20 Apr 2026 11:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "A Look Back at Biotechnology Stocks\u2019 Q4 Earnings: Incyte (NASDAQ:INCY) Vs The Rest Of The Pack", "summary": "", "url": "https://news.google.com/rss/articles/CBMi5gFBVV95cUxNWEtsYkktQkxQRHpTMHJOZzJaN09fT3R5aUpjZ0xEQTZXZGlCVUk0alZrVXhIRERNOW9feVJ1X0R4VUI2Q0FjUGIwTWpIRXE2dXpCLW9NdVdoSEE5b0JEM18wN2FQSGdXMDZfOGJ3STJPUmQ2VVBIbUQ5djhTZ01RTmpxLTdKRmdhN0U3RE52N0dEUzh4VFZ5c3dDd0ppZ1VYeGc0Mm5oQlU5TGJlQldpVHpoVjlhdXZ6ek0yaTBuQV9UUjNFT19kWFZ4QVViODkwN2ppOFRQU3lHQ1IxdXhrRkFGS3E0QQ?oc=5", "source_name": "TradingView", "published_at": "2026-03-29T07:00:00+00:00", "published_display": "29 Mar 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "industry", "tier_label": "Industry context"}, {"title": "Radiopharm Theranostics Highlights 90% Positive RAD101 Interim Data, Eyes Phase III FDA Talks", "summary": "", "url": "https://news.google.com/rss/articles/CBMitgFBVV95cUxNR2Zxdld0cmtSZjk5M0NSY0Q5MFd3a05UTHBHNHo0Nmc3R25ELUpRS0Voc3NqdXJGTmlHQXFuOFNwN0tQMVdaME1aZ0Q2M28yOFBvZlN5TmR0R0VieGkzNzNqbERFMm9ibXR3YWxIX2dCWnJWQTFEMHlNTkVEVUR1TzUtcW1hem9iX2RTYlNGeUZ1dFdLZEpxOTIwam5qNFRENnFzeWRPRDRHMEtaYi1rcks2NjBDZw?oc=5", "source_name": "Market source", "published_at": "2026-03-25T07:00:00+00:00", "published_display": "25 Mar 2026 07:00", "sentiment": "positive", "sentiment_pct": 66, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Radiopharm: 'Hold' As Theranostics Pipeline Has Several 2026 Milestones (NASDAQ:RADX)", "summary": "", "url": "https://news.google.com/rss/articles/CBMirgFBVV95cUxNSWFjcEJ3Mm5abHpWNTRBQi0tXzVkcXBBZTlKQkpkRTlPeVlpc2RtMHJxaTV2UTUyMGdVUzU3TzM4dm12cDdvSW13OVpfbTFvZkhwX3Fwd1NrVnJOeVlvRVZ0ZVlqM09tbXRvRmhjajFSaUNKaVY5UjV4TGYtVXBVRFpTRWNOZVdYOFczcVY5NV85cXFLZjhMVC0tbC00aWE3OTg1Q0htcXR4LXFMNlE?oc=5", "source_name": "Seeking Alpha", "published_at": "2026-03-11T07:00:00+00:00", "published_display": "11 Mar 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Radiopharm Theranostics Surge: Buy or Sell?", "summary": "", "url": "https://news.google.com/rss/articles/CBMikAFBVV95cUxQdllPZ2RtV0N2a0ZVdUM3RFBBTDlyckJzUndIMmpqZVYwUFNQR0haN0Z2cXZXZjk3bGRYaG54cFJ5WUlIcXdoX0Iyd1ZrX213OGtqNWRkcWdQSTQ4OHBLSS0xdXRDU2NTOHNBVzhoX0tpaW9pYjBpcWpWTF9jdkZDNmVRdjVXbnZOZ2tDR3hFQnI?oc=5", "source_name": "timothysykes.com", "published_at": "2025-12-15T08:00:00+00:00", "published_display": "15 Dec 2025 08:00", "sentiment": "positive", "sentiment_pct": 66, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Radiopharm (RADX) Sees Slight Pessimism From Analysts", "summary": "", "url": "https://news.google.com/rss/articles/CBMiiwFBVV95cUxNNG1Kd1FIa3hwb2NkNVExM0JvaUZGOUNKMF80eFJPQk1yUm5GNnFMeFVuVjduQURYSmJwbjh4NUNqU2pKcEVWVWdHWkF3eEpNX3hhT3V2amRUNDV0blVRS0pUMl9vTnRkSjRDNUJqY0xkWFdOVElWTlZNY1p4WU9wVVc0SHdBYnhVTndJ?oc=5", "source_name": "Market source", "published_at": "2025-12-15T08:00:00+00:00", "published_display": "15 Dec 2025 08:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Tesla, iRobot, ServiceNow, Radiopharm Theranostics, Kyverna Therapeutics: Stocks Making The Biggest Moves Today", "summary": "", "url": "https://news.google.com/rss/articles/CBMiugFBVV95cUxQeWZwcnZFU3VsWXR0bEM1aG9BeHF1MEFFZXhuaEt5QXBrMU1qNDF2cTAyUXVDQUJrTnNYN0tidmwtODVwbmh1S1hqNjh2MDR3R0ZHMnZsLU1kSVpPMXBPcE5uMFU0M2c1VVI5WEU0c0NZejUwMnhaak93M19EaGhhRXRWNG16c0szSENVWVFMUDR4OGNSdDBEYlk4dzFaQnpCRk1TdFVxb1BZdHRScEc5eUFJR3I2a0dKS3c?oc=5", "source_name": "Stocktwits", "published_at": "2025-12-15T08:00:00+00:00", "published_display": "15 Dec 2025 08:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "What is the current Price Target and Forecast for Radiopharm Theranostics Limited - Sponsored ADR (RADX)", "summary": "", "url": "https://news.google.com/rss/articles/CBMieEFVX3lxTFBLV0xnXzBRLUFWeVdKb1FzZXhEckdWVW12azhnMFBRcHpkVTdWWGtyZVM0LUdiRVNnX2FSa2RBQWpXYnNOSzFFRnB3TXBLVGJuQ1hJU0hFMnpWSGRRUnk4dDRXc0oyNjM2OG82UEZxUWY4R1RrNDJpYg?oc=5", "source_name": "Zacks Investment Research", "published_at": "2025-07-16T02:12:48+00:00", "published_display": "16 Jul 2025 02:12", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "guidance", "event_label": "Guidance", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "RADX SEC Filings - Radiopharm Theranostics Ltd 10-K, 10-Q, 8-K Forms", "summary": "", "url": "https://news.google.com/rss/articles/CBMiV0FVX3lxTE5uc0hIUThlTlFGcnpIYzVjb3R2M1pyY3VPZkFoUUZsVUE2dV9LUFlvN0pmMUNkOVB0WnoxaWZxbC13aFpkUUY3cEZGWlNmXzRoWU50d2xpMA?oc=5", "source_name": "Stock Titan", "published_at": "2025-06-29T03:59:20+00:00", "published_display": "29 Jun 2025 03:59", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Radiopharm Theranostics Limited (NASDAQ: RADX) - Share Price", "summary": "", "url": "https://news.google.com/rss/articles/CBMirAFBVV95cUxPb0ZiR2J6V0p5UHdCSXBKZnpKRG1RdmZwZFYyYVpHRTZqNU9LQnJUQWJpNkVGZkx5bzB0OWlhNnF6Y2RsSkI5RnNUNXRuMUNlOXY3SUctclowTHVkNmViSnYzYkJKclJnTTNOYm54MWhNTUYwanhrbkZtaW9CLTk4THZxZU5RcGxreGxmenhPZmM0MVpqcUJaTllhR2FDOUpxcnRKeVA2SHFpbFlV?oc=5", "source_name": "intelligentinvestor.com.au", "published_at": "2025-06-10T19:48:14+00:00", "published_display": "10 Jun 2025 19:48", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Radiopharm Theranostics (RADX) Stock Forecast and Price Target 2026", "summary": "", "url": "https://news.google.com/rss/articles/CBMiZkFVX3lxTE5sNFBIS0t4dUxJYXRwOTV0VHNWTHR5c2hSQmYtZHN5Nk9QdlhpUjVlTlF6TmpXUTRIZ0dkeW9XeHpuVm02REhOTnZ2cjJucDU3MHphMVlnaWtUdU8waVJRdm1oam5aQQ?oc=5", "source_name": "MarketBeat", "published_at": "2025-05-01T13:28:57+00:00", "published_display": "01 May 2025 13:28", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "guidance", "event_label": "Guidance", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Radiopharm Theranostics (RADX) Stock Price, News & Analysis", "summary": "", "url": "https://news.google.com/rss/articles/CBMiU0FVX3lxTE5lNkpwMXhEbjl0ZG1mU1JhNXE5aExTb2NTN3BJR3liWlpaTURuWG5sakk1ZnlfTGMwRDdkdUtsa2xyejhhTmhCdFJ2WFRiWG5BcEpN?oc=5", "source_name": "Stock Titan", "published_at": "2025-04-26T05:05:28+00:00", "published_display": "26 Apr 2025 05:05", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}], "by_tier": {"direct": [{"title": "A$5,885,131 R&D tax refund supports Radiopharm Theranostics (Nasdaq: RADX)", "summary": "", "url": "https://news.google.com/rss/articles/CBMiwAFBVV95cUxOSVJ0WHdqMURkdlFYQ2tFLTdiTEc1X185LXlwM3UtUmpyek9Hb2NTdlp0ejBFRUxxWWg0VzRwU29CTWFIN3hFZnhrY0hPQ1dibDVoUWJFc1huaUlTZ1dhaE5TYUVnZ1Z4VURnMHVBQmZTeHF4VDc3UHdNeE5qWHFYbTB1OE9CRmpZNHFNR0plYmNfWVhNSFpVUEMyYldLN0hLQlNUZVNhZktTSVlDOUJ2V2FoMURJcjI5SHRuTnpYS3Y?oc=5", "source_name": "Stock Titan", "published_at": "2026-07-06T07:00:00+00:00", "published_display": "06 Jul 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Theranostics (NASDAQ: RADX) reports option lapses and new RADAN grants", "summary": "", "url": "https://news.google.com/rss/articles/CBMiwAFBVV95cUxNQmNpMzlMSEhwbWNIaDZzNHZvOGtEU1BnbEdzdzg1andGSkQwRW9Ydk1pRkpmUC1oMjVGemZ1SXBhUzJPckZfZjZqTVVncFU5U2RaSTYwalRNc2JueEQyY1lWU1k0c3R0Z0lmTVV3ZXZJdzQ1ZWpDTWZXQld4ZDNMclRhNnlkS0s4ZktEdTJCbG9ycVpWeXBzX1B6a1FIRE9iTnFpcW15aWJ4cWswWkVfQVJ3ckk5TWpaRWpHZFRqZDA?oc=5", "source_name": "Stock Titan", "published_at": "2026-06-30T07:00:00+00:00", "published_display": "30 Jun 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Radiopharm Theranostics Ltd (RADX) Institutional Confidence", "summary": "", "url": "https://news.google.com/rss/articles/CBMicEFVX3lxTE9kNDUxMlRHdkZVc0hPSGxLUzlLWDhhX1NZUDJrM2ZzN3BZZlFDbFl6RTBFc1poc1JaemNHNlRHdkNfVmlFYml3LXo0bGxiRmhaN0FQbXpfdjFSZHR6c1lBdVRiYU1DQWpUMDM3WW5wal8?oc=5", "source_name": "TradingKey", "published_at": "2026-06-18T01:48:47+00:00", "published_display": "18 Jun 2026 01:48", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Radiopharm Theranostics (RADX) Gains 1.73% as Stock Hovers Above Key Support at $4.13 - Double Top", "summary": "", "url": "https://news.google.com/rss/articles/CBMiwgFBVV95cUxPSERYaTFmT0VYcGxtUFN4MWN1NzBEUVA5eEVxR19UZ29BY0lzYkxFeW5jQ05BMldfMWZxejRIN0wyVzNreHRJZVhLeW5wYy1nSkZOMkEzTk5fb2lhZzFMSEx2TzRBVGdRcFREc2RJMDl5N0JKVnV4djBpZnlZSER6Y3hiUzc3WVAtUk1PYXNGd1htUnJuUEZIOGtMbzRjbF82WUpfRHF0a2wxSkFkNEFqdkFwUnNud2hyQVRNNVh2cjBHQQ?oc=5", "source_name": "dars.gov.et", "published_at": "2026-06-10T07:00:00+00:00", "published_display": "10 Jun 2026 07:00", "sentiment": "positive", "sentiment_pct": 66, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Radiopharm Theranostics (RADX) Gains Ground: Testing Key Resistance at $4.85 - Fear Greed Extreme", "summary": "", "url": "https://news.google.com/rss/articles/CBMitwFBVV95cUxOVkdwNGhraGpSUG9tOVhlOVpDSDJqVGVaS3R1QUZCQ21OMTNEZFN3X0R2Mlp1N3RTU2xycUpQcExrNW95LVhUNGZYSXpqYy1qbzN2NnZUR2hNVG5qZGlMdXV6TGFrWk5xcWF3aWN6dnhJN2lLa2p0MkVNV0VTTFpxcUNTelRzc3gyUkVuUERQVVdiZk9NVDd3X2VjYWtBQUZEb1FTYzBEZ0V4YTVpckxyb05LcDE3Mms?oc=5", "source_name": "dars.gov.et", "published_at": "2026-05-28T07:00:00+00:00", "published_display": "28 May 2026 07:00", "sentiment": "positive", "sentiment_pct": 66, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Radiopharm Theranostics Highlights Phase 1 Pipeline, Eyes June RAD 101 Data at DB Conference", "summary": "", "url": "https://finance.yahoo.com/m/248f9258-8866-3027-a2da-7b029e642c2b/radiopharm-theranostics.html", "source_name": "MarketBeat", "published_at": "2026-04-29T09:04:38+00:00", "published_display": "29 Apr 2026 09:04", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Radiopharm Theranostics ADR (RADX): Inside the Clinical Programs", "summary": "", "url": "https://news.google.com/rss/articles/CBMirAFBVV95cUxNRGstejdNa3B1OXpsaEJ3dk5ibVJicl9QLXhfSFIyamdxLVdEajNWbG1HeTFZMnBGNWEtOHZZVHFlaXdDU2t4UkI3YkFHeUZ5dmZvVzNiVXJweU1zQzVGZzZRUWxKRG1PUmtHMXVQUVJucFUwTlVvajlCLWFyVWwyLWt2M3dFY0VfOVBHUV9zM2FpOXZfTHhhQlJBb0VMY20zYVRGb2ZNMUlpUks4?oc=5", "source_name": "Market source", "published_at": "2026-04-28T07:00:00+00:00", "published_display": "28 Apr 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "International companies to host live webcasts at Deutsche Bank\u2019s Depositary Receipts Virtual Investor Conference on April 28, 2026", "summary": "", "url": "https://finance.yahoo.com/markets/world-indices/articles/international-companies-host-live-webcasts-123500314.html", "source_name": "GlobeNewswire", "published_at": "2026-04-23T12:35:00+00:00", "published_display": "23 Apr 2026 12:35", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Radiopharm Theranostics Reports Business Update", "summary": "", "url": "https://news.google.com/rss/articles/CBMirgFBVV95cUxOc2dKN3BtcF82TlJscmVWMEQ0Y0N3U2dxek42VVQxLXB0WWNDNVdiNGZuaTVLc25zNlo3emdtUHlsNE5wN1N6SVEyYTlCV01oT1lUWlZpLW5SQ0VIelRDdkFDbVBicVBkeUVvUWdMWUdfTUtwcjlxTEpPcUF0bFIxX3V2VlhDY2ZlZTg4TUpYd1htU243X01XN255N2U0VHZzLTFpMUZiZEVkQXFFMXc?oc=5", "source_name": "Market source", "published_at": "2026-04-23T07:00:00+00:00", "published_display": "23 Apr 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Radiopharm Theranostics Presents Initial Findings from Phase 1 First-in-Human HEAT Clinical Trial for 177Lu-RAD202 in HER2+ Solid Tumors at American Association for Cancer Research 2026", "summary": "", "url": "https://finance.yahoo.com/sectors/healthcare/articles/radiopharm-theranostics-presents-initial-findings-110000207.html", "source_name": "GlobeNewswire", "published_at": "2026-04-20T11:00:00+00:00", "published_display": "20 Apr 2026 11:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Radiopharm Theranostics Highlights 90% Positive RAD101 Interim Data, Eyes Phase III FDA Talks", "summary": "", "url": "https://news.google.com/rss/articles/CBMitgFBVV95cUxNR2Zxdld0cmtSZjk5M0NSY0Q5MFd3a05UTHBHNHo0Nmc3R25ELUpRS0Voc3NqdXJGTmlHQXFuOFNwN0tQMVdaME1aZ0Q2M28yOFBvZlN5TmR0R0VieGkzNzNqbERFMm9ibXR3YWxIX2dCWnJWQTFEMHlNTkVEVUR1TzUtcW1hem9iX2RTYlNGeUZ1dFdLZEpxOTIwam5qNFRENnFzeWRPRDRHMEtaYi1rcks2NjBDZw?oc=5", "source_name": "Market source", "published_at": "2026-03-25T07:00:00+00:00", "published_display": "25 Mar 2026 07:00", "sentiment": "positive", "sentiment_pct": 66, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Radiopharm: 'Hold' As Theranostics Pipeline Has Several 2026 Milestones (NASDAQ:RADX)", "summary": "", "url": "https://news.google.com/rss/articles/CBMirgFBVV95cUxNSWFjcEJ3Mm5abHpWNTRBQi0tXzVkcXBBZTlKQkpkRTlPeVlpc2RtMHJxaTV2UTUyMGdVUzU3TzM4dm12cDdvSW13OVpfbTFvZkhwX3Fwd1NrVnJOeVlvRVZ0ZVlqM09tbXRvRmhjajFSaUNKaVY5UjV4TGYtVXBVRFpTRWNOZVdYOFczcVY5NV85cXFLZjhMVC0tbC00aWE3OTg1Q0htcXR4LXFMNlE?oc=5", "source_name": "Seeking Alpha", "published_at": "2026-03-11T07:00:00+00:00", "published_display": "11 Mar 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Radiopharm Theranostics Surge: Buy or Sell?", "summary": "", "url": "https://news.google.com/rss/articles/CBMikAFBVV95cUxQdllPZ2RtV0N2a0ZVdUM3RFBBTDlyckJzUndIMmpqZVYwUFNQR0haN0Z2cXZXZjk3bGRYaG54cFJ5WUlIcXdoX0Iyd1ZrX213OGtqNWRkcWdQSTQ4OHBLSS0xdXRDU2NTOHNBVzhoX0tpaW9pYjBpcWpWTF9jdkZDNmVRdjVXbnZOZ2tDR3hFQnI?oc=5", "source_name": "timothysykes.com", "published_at": "2025-12-15T08:00:00+00:00", "published_display": "15 Dec 2025 08:00", "sentiment": "positive", "sentiment_pct": 66, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Radiopharm (RADX) Sees Slight Pessimism From Analysts", "summary": "", "url": "https://news.google.com/rss/articles/CBMiiwFBVV95cUxNNG1Kd1FIa3hwb2NkNVExM0JvaUZGOUNKMF80eFJPQk1yUm5GNnFMeFVuVjduQURYSmJwbjh4NUNqU2pKcEVWVWdHWkF3eEpNX3hhT3V2amRUNDV0blVRS0pUMl9vTnRkSjRDNUJqY0xkWFdOVElWTlZNY1p4WU9wVVc0SHdBYnhVTndJ?oc=5", "source_name": "Market source", "published_at": "2025-12-15T08:00:00+00:00", "published_display": "15 Dec 2025 08:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Tesla, iRobot, ServiceNow, Radiopharm Theranostics, Kyverna Therapeutics: Stocks Making The Biggest Moves Today", "summary": "", "url": "https://news.google.com/rss/articles/CBMiugFBVV95cUxQeWZwcnZFU3VsWXR0bEM1aG9BeHF1MEFFZXhuaEt5QXBrMU1qNDF2cTAyUXVDQUJrTnNYN0tidmwtODVwbmh1S1hqNjh2MDR3R0ZHMnZsLU1kSVpPMXBPcE5uMFU0M2c1VVI5WEU0c0NZejUwMnhaak93M19EaGhhRXRWNG16c0szSENVWVFMUDR4OGNSdDBEYlk4dzFaQnpCRk1TdFVxb1BZdHRScEc5eUFJR3I2a0dKS3c?oc=5", "source_name": "Stocktwits", "published_at": "2025-12-15T08:00:00+00:00", "published_display": "15 Dec 2025 08:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "What is the current Price Target and Forecast for Radiopharm Theranostics Limited - Sponsored ADR (RADX)", "summary": "", "url": "https://news.google.com/rss/articles/CBMieEFVX3lxTFBLV0xnXzBRLUFWeVdKb1FzZXhEckdWVW12azhnMFBRcHpkVTdWWGtyZVM0LUdiRVNnX2FSa2RBQWpXYnNOSzFFRnB3TXBLVGJuQ1hJU0hFMnpWSGRRUnk4dDRXc0oyNjM2OG82UEZxUWY4R1RrNDJpYg?oc=5", "source_name": "Zacks Investment Research", "published_at": "2025-07-16T02:12:48+00:00", "published_display": "16 Jul 2025 02:12", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "guidance", "event_label": "Guidance", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "RADX SEC Filings - Radiopharm Theranostics Ltd 10-K, 10-Q, 8-K Forms", "summary": "", "url": "https://news.google.com/rss/articles/CBMiV0FVX3lxTE5uc0hIUThlTlFGcnpIYzVjb3R2M1pyY3VPZkFoUUZsVUE2dV9LUFlvN0pmMUNkOVB0WnoxaWZxbC13aFpkUUY3cEZGWlNmXzRoWU50d2xpMA?oc=5", "source_name": "Stock Titan", "published_at": "2025-06-29T03:59:20+00:00", "published_display": "29 Jun 2025 03:59", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Radiopharm Theranostics Limited (NASDAQ: RADX) - Share Price", "summary": "", "url": "https://news.google.com/rss/articles/CBMirAFBVV95cUxPb0ZiR2J6V0p5UHdCSXBKZnpKRG1RdmZwZFYyYVpHRTZqNU9LQnJUQWJpNkVGZkx5bzB0OWlhNnF6Y2RsSkI5RnNUNXRuMUNlOXY3SUctclowTHVkNmViSnYzYkJKclJnTTNOYm54MWhNTUYwanhrbkZtaW9CLTk4THZxZU5RcGxreGxmenhPZmM0MVpqcUJaTllhR2FDOUpxcnRKeVA2SHFpbFlV?oc=5", "source_name": "intelligentinvestor.com.au", "published_at": "2025-06-10T19:48:14+00:00", "published_display": "10 Jun 2025 19:48", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Radiopharm Theranostics (RADX) Stock Forecast and Price Target 2026", "summary": "", "url": "https://news.google.com/rss/articles/CBMiZkFVX3lxTE5sNFBIS0t4dUxJYXRwOTV0VHNWTHR5c2hSQmYtZHN5Nk9QdlhpUjVlTlF6TmpXUTRIZ0dkeW9XeHpuVm02REhOTnZ2cjJucDU3MHphMVlnaWtUdU8waVJRdm1oam5aQQ?oc=5", "source_name": "MarketBeat", "published_at": "2025-05-01T13:28:57+00:00", "published_display": "01 May 2025 13:28", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "guidance", "event_label": "Guidance", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Radiopharm Theranostics (RADX) Stock Price, News & Analysis", "summary": "", "url": "https://news.google.com/rss/articles/CBMiU0FVX3lxTE5lNkpwMXhEbjl0ZG1mU1JhNXE5aExTb2NTN3BJR3liWlpaTURuWG5sakk1ZnlfTGMwRDdkdUtsa2xyejhhTmhCdFJ2WFRiWG5BcEpN?oc=5", "source_name": "Stock Titan", "published_at": "2025-04-26T05:05:28+00:00", "published_display": "26 Apr 2025 05:05", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}], "industry": [{"title": "Q1 Earnings Highs And Lows: Natera (NASDAQ:NTRA) Vs The Rest Of The Biotechnology Stocks", "summary": "", "url": "https://news.google.com/rss/articles/CBMilAFBVV95cUxNYmZ3aHMyMjBuNmlEUGN6NWZBZV85cEFWNndJaVNoNEVYNk84MlNKRXJ0RXpRQl9wN1RsekhxM3loY1RRNDJhTnVremtReHhLQWVHS053VzRBUTduSkdqRGt1YkxMMThqZHoydElPX1Zfd3hEMi15VlRwRGRvZ2JqRDFneVVxN0JCYzQ4QlV5TTBEOWx3?oc=5", "source_name": "Market source", "published_at": "2026-07-16T18:49:22+00:00", "published_display": "16 Jul 2026 18:49", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "industry", "tier_label": "Industry context"}, {"title": "Unpacking Q1 Earnings: Incyte (NASDAQ:INCY) In The Context Of Other Biotechnology Stocks", "summary": "", "url": "https://news.google.com/rss/articles/CBMigAJBVV95cUxPV1hqSFhQM3VfYlNsdldfeVQ1dEdNNzI3S1RTaFJNSThrOXlPSWpMTlR5WWVxNnNsTzhTVGVvTE94R18wa1A0OUdFczBlcTIzeUFBZUt6VVJJMjNqNks3dmRUSzB4cE40anpNekJwUXAwcTFEcVh4QVZCYURXY2w4b2thdk5KZ3ZJMnI1REJObXo5UDdISXVCU1Z2ZVZoVmJpbnEzaDVWVmpGQVNFZzRXYnp0SWRRWWZGSnZnWlJ4aEloNmJBNGRMVFRjb3ZRbmV3QXF5S0pvTV9xNnpaMWV1Z1ZtM3lPdV9RcEdURHlfZFphdjlicEJndW0ybHNBa205?oc=5", "source_name": "The Globe and Mail", "published_at": "2026-07-13T03:32:00+00:00", "published_display": "13 Jul 2026 03:32", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "industry", "tier_label": "Industry context"}, {"title": "There May Be Reason For Hope In Puma Biotechnology's (NASDAQ:PBYI) Disappointing Earnings", "summary": "", "url": "https://news.google.com/rss/articles/CBMi5wFBVV95cUxQcjZqdzdBcURDdWxCZUtoU1dTaHYtVUFRdlo1a3ZGZGY3a1dBX2x2UVE3Y1hoX1duLXhGU2p0UXU2eTctNng5eFJ5c1M0bHBNQ0VmZTFZanhYU21yTVo0UTQtVENveVV1aWdpc3luUlgza3AyUEI2OGx4aEhXc0pBTHpWUThSYXI1S3RTS21lQ21vWjd6MGY4ZDRwVWlEakc3SmFKN09aM0Rlb2pFT3BNNW1GTExnSElFb2NqR3JhX0J3MlptQy1mMk9IOTZtdS1HU25fLU9aOU9XZi1PRDlkZVI2cnhackHSAewBQVVfeXFMTlc2N3pIUkxDd1NtTlVRMEdac1JNSDF3cUNidkZrTElQREZaUTZjZmFHdUVWYW8wcDg1LThGbnlPb0VQUFI4ZXdjSXR6Ym5DREM1X2lyQUtYTzF3XzBBTGRGcEZQQ3FjLWxCQ0locVM2dGZJR1kxYmlBQXdsbFhfbFFISS1wSUkxQmp4U2d2Z3JHbXRPMUpnajBydTRmNnQzZmF5eEdzOVFRNUdDNVV0aDJQNERCaXN3ZGo1UUc1ZGkwOFYzcDgxS1ltZllDeTFxNFIxT3FyOUxLMFNrLUhtOFNFV0xMYkM5TlpWMzk?oc=5", "source_name": "simplywall.st", "published_at": "2026-05-15T07:00:00+00:00", "published_display": "15 May 2026 07:00", "sentiment": "negative", "sentiment_pct": 34, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "industry", "tier_label": "Industry context"}, {"title": "Puma Biotechnology's (NASDAQ:PBYI) Conservative Accounting Might Explain Soft Earnings", "summary": "", "url": "https://news.google.com/rss/articles/CBMirgFBVV95cUxNZXcyN1VKc0J0RTFtSER6TGRSZm8xSWs2c0paem5paDd3V0J1cjF6ajhFb29tRFpUWWpxYUhzZjFkSXhYQ0lBNTVlbTdCRERpSXNjaGpDajFPOVlpRS1qV2xHMTRHS2pjVVBZMWFfNzItWE9FeENtQ2duMUxVQm5kOG41eVlrNUpObXp2VlhfekdhMVh2X0hjN3ZFZThZNUdWakFLUXJ4aFBVN2JyR2c?oc=5", "source_name": "Market source", "published_at": "2026-05-14T07:00:00+00:00", "published_display": "14 May 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "industry", "tier_label": "Industry context"}, {"title": "Puma Biotechnology, Inc. (NASDAQ:PBYI) Analysts Are Pretty Bullish On The Stock After Recent Results", "summary": "", "url": "https://news.google.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?oc=5", "source_name": "simplywall.st", "published_at": "2026-05-11T07:00:00+00:00", "published_display": "11 May 2026 07:00", "sentiment": "positive", "sentiment_pct": 66, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "industry", "tier_label": "Industry context"}, {"title": "Earnings Update: Here's Why Analysts Just Lifted Their Puma Biotechnology, Inc. (NASDAQ:PBYI) Price Target To US$5.00", "summary": "", "url": "https://news.google.com/rss/articles/CBMingFBVV95cUxPSUN3RjZYMEJ2VUdKQjJpRkZaUXRzM2NTa05WWmlmWHJnZDlJeUpTdFM5Wmk0SUhjclU2dldTZFIyRmZZeGJSNGM2SUNiSGJSYjh1VjYyR0hPZ2FJbWdsbHExYlhwMW1HRTZ0NUxwQzU1b2g4MGpwSHdoMkdIOUtqOXBBYk92LVk2cEFZMzVISjB3c04ydVBEYWw2cVVsdw?oc=5", "source_name": "Market source", "published_at": "2026-05-11T07:00:00+00:00", "published_display": "11 May 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "industry", "tier_label": "Industry context"}, {"title": "Q4 Earnings Highlights: Regeneron (NASDAQ:REGN) Vs The Rest Of The Biotechnology Stocks", "summary": "", "url": "https://news.google.com/rss/articles/CBMirAFBVV95cUxNWW9GYm5uRzlBX2ZiZXA3RkdDXzJhaFd2N1ZwR21jaXhiRkZQSTNHT0hMaUFjSGl6VXZfOURKemF2bWlFS1hKTXBjZUw4amdVQ0I4QlVnNmFkY1VTQ25pUjBiZGNDUE9QdWdOZHAxV1I1ejN6UE9WdGpseUdrMVA5MXBXWXJmWDBkZUdWUkxpOURCdlZlbDlQR3M5cjAzaDFtakFNblRTa3c0Q1J6?oc=5", "source_name": "Market source", "published_at": "2026-04-25T07:00:00+00:00", "published_display": "25 Apr 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "industry", "tier_label": "Industry context"}, {"title": "Biotechnology Stocks Q3 Results: Benchmarking Natera (NASDAQ:NTRA)", "summary": "", "url": "https://news.google.com/rss/articles/CBMiswFBVV95cUxPZzZDSEhwNlVYQU9kNXBMMU5ia0FTU0RxRlYwb0I1RERNODN4N0VwRFZWMUY4ODh3eWNkTkp0UERreFlSTllocGk4a2ZKcGlJVjQ4d1dXWlNnYTc5UlNMZm4wc2xITjRQVzhRb3Z5LXllQmhvUHNIaXB3LXk1RUw1WnRPam9wcVE1MXFxSmVzVF9MVmRyMWIwdVkxS1N3MUJZUzByLWxrVDlSSUk4QnNsXzJYbw?oc=5", "source_name": "Market source", "published_at": "2026-04-21T07:00:00+00:00", "published_display": "21 Apr 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "industry", "tier_label": "Industry context"}, {"title": "A Look Back at Biotechnology Stocks\u2019 Q4 Earnings: Incyte (NASDAQ:INCY) Vs The Rest Of The Pack", "summary": "", "url": "https://news.google.com/rss/articles/CBMi5gFBVV95cUxNWEtsYkktQkxQRHpTMHJOZzJaN09fT3R5aUpjZ0xEQTZXZGlCVUk0alZrVXhIRERNOW9feVJ1X0R4VUI2Q0FjUGIwTWpIRXE2dXpCLW9NdVdoSEE5b0JEM18wN2FQSGdXMDZfOGJ3STJPUmQ2VVBIbUQ5djhTZ01RTmpxLTdKRmdhN0U3RE52N0dEUzh4VFZ5c3dDd0ppZ1VYeGc0Mm5oQlU5TGJlQldpVHpoVjlhdXZ6ek0yaTBuQV9UUjNFT19kWFZ4QVViODkwN2ppOFRQU3lHQ1IxdXhrRkFGS3E0QQ?oc=5", "source_name": "TradingView", "published_at": "2026-03-29T07:00:00+00:00", "published_display": "29 Mar 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "industry", "tier_label": "Industry context"}], "sector": []}, "total_fetched": 65, "total_relevant": 29, "sentiment_summary": {"positive": 5, "negative": 1, "neutral": 23, "score": 52, "total": 29, "label": "Balanced news tone", "tone": "neutral"}, "classifier": {"primary_event": "general", "primary_label": "Market update", "confidence": 83, "events": [{"event": "general", "label": "Market update", "weight": 10.25, "count": 18}, {"event": "earnings", "label": "Earnings", "weight": 3.71, "count": 9}, {"event": "guidance", "label": "Guidance", "weight": 1.45, "count": 2}], "positive_events": 5, "negative_events": 1}, "market_context": {"has_market_context": true, "latest_close": 4.37, "latest_week": "2026-07-10", "one_week_move": 0.0, "four_week_move": 2.3, "twelve_week_move": -4.6, "trend_signal": "0", "trend_label": "Trend inactive", "trend_tone": "negative", "market_dynamics": 0.136509, "market_dynamics_buy_signal": false, "relative_strength": -25.378187, "fair_value_gap": -14.0, "fair_value_label": "Near fair-value range", "fair_value_tone": "neutral", "expectation_direction": "undecided", "expectation_probability": 49.9423, "reaction_label": "Price digesting", "reaction_tone": "neutral", "market_sentence": "+0.0% over one week, +2.3% over four weeks, trend inactive, and near fair-value range."}, "interpretation": {"label": "Balanced read", "tone": "neutral", "classification": "balanced", "summary": "News tone and price action are not far from neutral.", "confidence": 51, "badges": [], "opportunities": [], "risks": [], "event_label": "Market update", "sentiment_word": "balanced"}, "charts": {"sources": [{"label": "Market source", "count": 9}, {"label": "Stock Titan", "count": 4}, {"label": "dars.gov.et", "count": 2}, {"label": "simplywall.st", "count": 2}, {"label": "MarketBeat", "count": 2}, {"label": "GlobeNewswire", "count": 2}, {"label": "The Globe and Mail", "count": 1}, {"label": "TradingKey", "count": 1}], "tiers": [{"label": "Direct company coverage", "count": 20}, {"label": "Industry context", "count": 9}, {"label": "Sector context", "count": 0}], "events": [{"label": "Market update", "count": 18}, {"label": "Earnings", "count": 9}, {"label": "Guidance", "count": 2}]}, "insights": [{"label": "Weighted tone", "value": "52/100", "tone": "neutral", "text": "Balanced news tone"}, {"label": "Market reaction", "value": "Balanced read", "tone": "neutral", "text": "News tone and price action are not far from neutral."}, {"label": "Primary event", "value": "Market update", "tone": "neutral", "text": "83/100 classification confidence."}, {"label": "Company focus", "value": "20", "tone": "positive", "text": "directly relevant articles"}, {"label": "Source quality", "value": "2", "tone": "positive", "text": "high-authority source matches"}, {"label": "Trend context", "value": "Trend inactive", "tone": "negative", "text": "+0.0% over one week, +2.3% over four weeks, trend inactive, and near fair-value range."}, {"label": "Latest direct headline", "value": "Neutral", "tone": "neutral", "text": "A$5,885,131 R&D tax refund supports Radiopharm Theranostics (Nasdaq: RADX)"}], "updated_at": "2026-07-17T10:44:31.281030+00:00", "disclaimer": "Educational market research only. Not financial, investment, trading, tax, or legal advice."}